Rabies Immune Globulin (Human) from Japan
Passive antibody preparation from human plasma of vaccinated donors, used post-exposure prophylaxis for rabies. HTS 3002.12.0090 covers this as other antisera/blood fractions for prophylactic therapeutic use. Biotech processes ensure high potency against rabies virus.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Rabies neutralizing antibody (RFFIT) test reports mandatory for import validation
• Prior FDA notification via Prior Notice system for biologics expedites entry